Curcumin and trans-resveratrol exert cell cycle-dependent radioprotective or radiosensitizing effects as elucidated by the PCC and G2-assay

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 766-767, Issue , 2014, Pages 49-55

  Sebastia N ^a   Montoro, A ^a,b   Hervas D ^a   Pantelias, G ^c   Hatzi, V I ^c   Soriano, J M ^a,d   Villaescusa, J I ^b   Terzoudi, G I ^c  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Curcumin; G2 assay; Premature chromosome condensation; Radioprotector; Radiosensitizer; Trans Resveratrol

Indexed keywords

CURCUMIN; RESVERATROL; SCAVENGER; RADIOPROTECTIVE AGENT; RADIOSENSITIZING AGENT; STILBENE DERIVATIVE;

ANIMAL CELL; ARTICLE; ATAXIA TELANGIECTASIA; CANCER RADIOTHERAPY; CELL FUSION; CHROMOSOME BREAKAGE; CHROMOSOME DAMAGE; CONCENTRATION (PARAMETERS); DNA DAMAGE; DRUG MECHANISM; G2 CHROMOSOMAL RADIOSENSITIVITY ASSAY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IRRADIATION; NONHUMAN; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PREMATURE CHROMOSOME CONDENSATION; PRIORITY JOURNAL; RADIATION PROTECTION; RADIOSENSITIVITY; RADIOSENSITIZATION; UPREGULATION; ANIMAL; CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CHO CELL LINE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CRICETULUS; DRUG EFFECTS; HAMSTER; MUTAGEN TESTING; RADIATION DOSE;

ANIMALS; CELL CYCLE; CELL FUSION; CELLS, CULTURED; CHO CELLS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CRICETINAE; CRICETULUS; CURCUMIN; G2 PHASE; HUMANS; MUTAGENICITY TESTS; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; RADIATION-SENSITIZING AGENTS; STILBENES;

EID: 84903388657     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2014.05.006     Document Type: Article

References (27)

1. Hadi S.M., Bhat S.H., Azmi A.S., Hanif S., Shamim U., Ullah M.F. Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties. Semin. Cancer Biol. 2007, 17:370-376.
2. Perron N.R., García C.R., Pinzón J.R., Chaur M.N., Brumaghim J.L. Antioxidant and prooxidant effects of polyphenol compounds on copper-mediated DNA damage. J. Inorg. Biochem. 2011, 105:745-753.
3. Aftab N., Vieira A. Antioxidant activities of curcumin and combinations of this curcuminoid with other phytochemicals. Phytother. Res. 2010, 24:500-502.
4. Signorelli P., Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 2005, 16:449-466.
5. Shishodia S., Chaturvedi M.M., Aggarwal B.B. Role of curcumin in cancer therapy. Curr. Probl. Cancer 2007, 31:243-305.
6. Epstein J., Docena G., MacDonald T.T., Sanderson I.R. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br. J. Nutr. 2010, 103:824-832.
7. Koide K., Osman S., Garner A.L., Song F., Dixon T., Greenberger J.S., Epperly M.W. The use of 3,5,4'-tri-O-acetylresveratrol as a potential pro-drug for resveratrol protects mice from γ-irradiation-induced death. Chem. Lett. 2011, 2:270-274.
8. Goel A., Aggarwal B.B. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr. Cancer 2010, 62:919-930.
9. Zoberi I., Bradbury C.M., Curry H.A., Bisht K.S., Goswami P.C., Roti Roti J.L., Gius D. Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett. 2002, 175:165-173.
10. Veeraraghavan J., Natarajan M., Lagisetty P., Awasthi V., Herman T.S., Aravindan N. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells. Pancreas 2011, 40:1107-1119.
11. Fang Y., De Marco V.G., Nicholl M.B. Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci. 2012, 103:1090-1098.
12. Hatzi V.I., Terzoudi G.I., Makropoulos V., Pantelias G.E. A cytogenetic methodology to evaluate in vitro the G2-chromosomal radiosensitization induced by chemicals at non-clastogenic doses. J. Genet. 2009, 88:349-351.
13. Sebastià N., Montoro A., Montoro A., Almonacid M., Villaescusa J.I., Cervera J., Such E., Silla M.A., Soriano J.M. Assessment in vitro of radioprotective efficacy of curcumin and resveratrol. Radiat. Meas. 2011, 46:962-966.
14. Srinivasan M., Rajendra Prasad N., Menon V.P. Protective effect of curcumin on gamma-radiation induced DNA damage and lipid peroxidation in cultured human lymphocytes. Mutat. Res. 2006, 611:96-103.
15. Pantelias G.E., Maillie H.D. The measurement of immediate and persistent radiation-induced chromosome damage in rodent primary cells using premature chromosome condensation. Health Phys. 1985, 49:425-433.
16. Pantelias G.E., Maillie H.D. A simple method for premature chromosome condensation induction in primary human and rodent cells using polyethylene glycol. Somatic Cell Genet. 1983, 9:533-547.
17. Pantelias G.E., Terzoudi G.I. A standardized G2-assay for the prediction of individual radiosensitivity. Radiother. Oncol. 2011, 101:28-34.
18. Kunwar A., Barik A., Mishra B., Rathinasamy K., Pandey R., Priyadarsini K.I. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim. Biophys. Acta 2008, 1780:673-679.
19. Lançon A., Hanet N., Jannin B., Delmas D., Heydel J.M., Lizard G., Chagnon M.C., Artur Y., Latruffe N. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab. Dispos. 2007, 35:699-703.
20. Delmas D., Aires V., Limagne E., Dutartre P., Mazu F., Ghiringhelli F., Latruffe N. Transport, stability, and biological activity of resveratrol. Ann. N. Y. Acad. Sci. 2011, 1215:48-59.
21. Kasten-Pisula U., Windhorst S., Dahm-Daphi J., Mayr G., Dikomey E. Radiosensitization of tumor cell lines by the polyphenol Gossypol results from depressed double-strand break repair and not from enhanced apoptosis. Radiother. Oncol. 2007, 83:296-303.
22. Pantelias G.E., Terzoudi G.I. Functional cell-cycle chromatin conformation changes in the presence of DNA damage result into chromatid breaks: a new insight in the formation of radiation-induced chromosomal aberrations based on the direct observation of interphase chromatin. Mutat. Res. 2010, 701:27-37.
23. Terzoudi G.I., Hatzi V.I., Donta-Bakoyianni C., Pantelias G.E. Chromatin dynamics during cell cycle mediate conversion of DNA damage into chromatid breaks and affect formation of chromosomal aberrations: biological and clinical significance. Mutat. Res. 2011, 711:174-186.
24. Chendil D., Ranga R.S., Meigooni D., Sathishkumar S., Ahmed M.M. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004, 23:1599-1607.
25. Fiore M., Festa F., Cornetta T., Ricordy R., Cozzi R. Resveratrol affects X-ray induced apoptosis and cell cycle delay in human cells in vitro. Int. J. Mol. Med. 2005, 15:1005-1112.
26. Hatzi V.I., Terzoudi G.I., Makropoulos V., Maravelias C., Pantelias G.E. Pre-irradiation exposure of peripheral blood lymphocytes to glutaraldehyde induces radiosensitization by increasing the initial yield of radiation-induced chromosomal aberrations. Mutagenesis 2008, 23:101-109.
27. Hatzi V.I., Terzoudi G.I., Pantelias G.E., Spiliopoulou C., Makropoulos V. The benzene metabolite hydroquinone enhances G2-chromosomal radiosensitivity by inducing a less-efficient G2-M-checkpoint in irradiated lymphocytes. Int. J. Oncol. 2007, 31:145-152.